RT @OMaxFisher: Median survival ~30months and median 5 year survival ~30% but only if CC0/1 and PCIs >15 do worse...very similar to colorec…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @A_GangiMD: Multi-institutional study - Improved OS w/ CRS+HIPEC for #SmallBowelAdenocarcinoma in pts w/ well diff tumors, no LN mets du…
RT @A_GangiMD: Multi-institutional study - Improved OS w/ CRS+HIPEC for #SmallBowelAdenocarcinoma in pts w/ well diff tumors, no LN mets du…
Multi-institutional study - Improved OS w/ CRS+HIPEC for #SmallBowelAdenocarcinoma in pts w/ well diff tumors, no LN mets during CRS+HIPEC, PCI of 15 or less, and interval of <6 mos from detection of PM to CRS+HIPEC #HIPEC @HipecMichigan #CancerResearch
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a #SmallBowelAdenocarcinoma: Multi-Institutional Experience. #HIPEC . https://t.co/m5ejdwVuT8 @McMastersKelly @SocSurgOnc https://t.co/
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
RT @AnnSurgOncol: ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From…
ASO Visual Abstract: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a #SmallBowelAdenocarcinoma: Multi-Institutional Experience. #HIPEC . https://t.co/m5ejdwVuT8 https://t.co/mjOoBsGe3y
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @OMaxFisher: Median survival ~30months and median 5 year survival ~30% but only if CC0/1 and PCIs >15 do worse...very similar to colorec…
RT @OMaxFisher: Median survival ~30months and median 5 year survival ~30% but only if CC0/1 and PCIs >15 do worse...very similar to colorec…
RT @OMaxFisher: Median survival ~30months and median 5 year survival ~30% but only if CC0/1 and PCIs >15 do worse...very similar to colorec…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @OMaxFisher: Median survival ~30months and median 5 year survival ~30% but only if CC0/1 and PCIs >15 do worse...very similar to colorec…
Median survival ~30months and median 5 year survival ~30% but only if CC0/1 and PCIs >15 do worse...very similar to colorectal cancer #CRS #HIPEC #PeritonealMetastases #peritonectomy https://t.co/5ecgIuOX08
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
RT @AnnSurgOncol: MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bo…
MAY ISSUE: Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for #PeritonealMetastases From a Small Bowel #Adenocarcinoma: Multi-Institutional Experience. https://t.co/AWBhfKxE3S https://t.co/mXwRWtqQrC
HIPEC for Small Bowel Adenocarcinoma https://t.co/GvwDKtCTuF